WHO ICTRP trial
Maintenance of platelet inhiBition with cangreloR after dIscontinuation of…
NL-OMON34815 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON34815 |
|---|---|
| Public title | Maintenance of platelet inhiBition with cangreloR after dIscontinuation of thienopyriDines in patients undergoing surGEry: The BRIDGE trial |
| Scientific title | Maintenance of platelet inhiBition with cangreloR after dIscontinuation of thienopyriDines in patients undergoing surGEry: The BRIDGE trial - BRIDGE |
| Primary sponsor | Medicines Company |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | Austria;Bulgaria;Czechia;Germany;Italy;Lithuania;Netherlands ;Poland;Slovakia;Spain |
| Conditions | platelet inhibition;10011082;platelet inhibition |
| Interventions | not applicable ;acute coronary syndrome;CABG;platelet inhibition;thienopyridine |
| Registration date | Oct 19, 2010 |
| Target size | 50 |
| Secondary IDs | 2008-001135-35;NL31843.100.10 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: